Different estimates say vaccine cuts infection rates by up to 60 percent 14 days after first jab
As Israel's COVID-19 coronavirus vaccination campaign steams ahead, the first studies of the Pfizer jab's efficiency appear to largely confirm the company's own estimates.
Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more
Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens
A major study conducted by Clalit healthcare provider demonstrated that the Pfizer vaccine was able to slash infections by about one-third 14 days after the first shot had been administered, Israel's Channel 13 reported Tuesday.
The estimate is based on a comparison of 200,000 Israelis aged 60 and more who received the first shot and had to test for COVID-19 -- and a non-inoculated group of the same size and age.